Table of Contents
Ocular Complications from Chemotherapeutic Agents
MEK inhibitors
References
Ocular Complications from Chemotherapeutic Agents
MEK inhibitors
Selumetinib, Binimetinib, Trametinib, Cobimetinib
Blurred vision, diplopia, eyelid edema, subconjunctival hemorrhage, increased lacrimation
Retinal pigment epithelial detachment, Central serous-like retinopathy
References
Ocular toxicities of MEK inhibitors and other targeted therapies. Stjepanovic et al. Annals of Oncology.Volume 27, Issue 6, June 2016, Pages 998-1005
Clinical and Morphological Characteristics of MEK Inhibitor-Associated Retinopathy. Francis, Jasmine H. et al. Ophthalmology. 2017-12, Vol.124 (12), p.1788-1798